IL-1β and IL-18 can differently promote tumor progression, e.g. by aggravating chronic inflammation, promoting cancer cell proliferation, angiogenesis, and tumor evasion from immune surveillance, but described protumorigenic actions depend on many variables such as tumor type, expression characteristics, and cell source of proinflammatory cytokine92,99–101. Here, IL1B is linked to neoplasm.